Artizan Biosciences Closes $11 Million Series A-2 Financing and Enters Option and License Agreement with Biohaven Therapeutics

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/3e3dtET
via IFTTT